SR 33805

highly selective for vascular smooth muscle & devoid of any potent negative inotropic actions; structure given in first source; RN given refers to parent cpd

Also Known As:

SR 33805 oxalate; SR-33805

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - SR 33805: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfones: 534
    - SR 33805: 1

Related Diseases

1.	Neointima 07/04/1995 - "Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury."
2.	Vascular System Injuries 07/04/1995 - "Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury."
3.	Atherosclerosis 07/04/1995 - "The possible activity of SR 33805 ([[N-[dimethoxy-3,4-phenethyl]-N- methylamino-propoxyl]-4-benzenesulfonyl]-2-isopropyl-3-methyl-1-in dole), a novel Ca2+ channel blocker, in early atherogenesis was investigated. "
4.	Hyperplasia 07/04/1995 - "SR 33805 inhibited serum-stimulated 45Ca2+ uptake in these cells, with an IC50 value of 47 +/- 18 nM. The effect of SR 33805 on intimal smooth muscle hyperplasia in rabbit carotid arteries subjected to air-drying endothelial injury was then investigated. "